Evaluation of N-acetyl-beta-glucosaminidase in two groups of renal transplant recipients undergoing conventional and cyclosporin A therapy: 48 months follow-up.
D000118:Acetylglucosaminidase / Q000652:urine*; D000328:Adult; D003524:Cyclosporins / Q000009:adverse effects*; D005500:Follow-Up Studies; D006596:Hexosaminidases / Q000652:urine*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects; D007668:Kidney / Q000187:drug effects*; D016030:Kidney Transplantation; D008875:Middle Aged; D013997:Time Factors
D003524:Cyclosporins; D007166:Immunosuppressive Agents; D006596:Hexosaminidases; D000118:Acetylglucosaminidase